ZA200908202B - A medicament comprising a carbostyril derivates and donepezil for treating alzheimer's disease - Google Patents
A medicament comprising a carbostyril derivates and donepezil for treating alzheimer's diseaseInfo
- Publication number
- ZA200908202B ZA200908202B ZA200908202A ZA200908202A ZA200908202B ZA 200908202 B ZA200908202 B ZA 200908202B ZA 200908202 A ZA200908202 A ZA 200908202A ZA 200908202 A ZA200908202 A ZA 200908202A ZA 200908202 B ZA200908202 B ZA 200908202B
- Authority
- ZA
- South Africa
- Prior art keywords
- carbostyril
- donepezil
- derivates
- medicament
- disease
- Prior art date
Links
- ADEBPBSSDYVVLD-UHFFFAOYSA-N donepezil Chemical compound O=C1C=2C=C(OC)C(OC)=CC=2CC1CC(CC1)CCN1CC1=CC=CC=C1 ADEBPBSSDYVVLD-UHFFFAOYSA-N 0.000 title 2
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical compound C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 title 2
- 208000024827 Alzheimer disease Diseases 0.000 title 1
- 229960003530 donepezil Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007135367 | 2007-05-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200908202B true ZA200908202B (en) | 2010-07-28 |
Family
ID=39636992
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200908202A ZA200908202B (en) | 2007-05-22 | 2009-11-20 | A medicament comprising a carbostyril derivates and donepezil for treating alzheimer's disease |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US20100298375A1 (https=) |
| EP (2) | EP2937085B1 (https=) |
| JP (1) | JP5153870B2 (https=) |
| KR (1) | KR101441725B1 (https=) |
| CN (1) | CN101754758B (https=) |
| AR (1) | AR066664A1 (https=) |
| AU (1) | AU2008253977B2 (https=) |
| BR (1) | BRPI0811919A2 (https=) |
| CA (1) | CA2687289C (https=) |
| CO (1) | CO6251249A2 (https=) |
| CY (1) | CY1116683T1 (https=) |
| DK (1) | DK2157973T3 (https=) |
| ES (1) | ES2545959T3 (https=) |
| HR (1) | HRP20150843T1 (https=) |
| HU (1) | HUE025902T2 (https=) |
| IL (1) | IL202053A (https=) |
| MX (1) | MX2009012583A (https=) |
| MY (1) | MY146407A (https=) |
| NZ (1) | NZ581099A (https=) |
| PL (1) | PL2157973T3 (https=) |
| PT (1) | PT2157973E (https=) |
| RU (1) | RU2469723C2 (https=) |
| SI (1) | SI2157973T1 (https=) |
| TW (2) | TWI489983B (https=) |
| UA (1) | UA96633C2 (https=) |
| WO (1) | WO2008143361A1 (https=) |
| ZA (1) | ZA200908202B (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2135607A1 (en) | 2008-06-18 | 2009-12-23 | Pharnext | Combination of pilocarpin and methimazol for treating Charcot-MarieTooth disease and related disorders |
| US9387206B2 (en) | 2009-11-03 | 2016-07-12 | Pharnext | Therapeutic approaches for treating Alzheimer's disease |
| EP2322163A1 (en) * | 2009-11-03 | 2011-05-18 | Pharnext | New therapeutics approaches for treating alzheimer disease |
| US9241933B2 (en) | 2011-03-01 | 2016-01-26 | Pharnext | Compositions for treating amyotrophic lateral sclerosis |
| US10010515B2 (en) | 2011-03-01 | 2018-07-03 | Pharnext | Therapeutic approaches for treating Parkinson's disease |
| TR201809351T4 (tr) | 2011-03-01 | 2018-07-23 | Pharnext | Nörolojik bozuklukların baklofen ve akamprosat tabanlı terapisi. |
| US9248111B2 (en) | 2011-03-01 | 2016-02-02 | Pharnext | Therapeutic approaches for treating parkinson's disease |
| KR20150027800A (ko) * | 2012-06-15 | 2015-03-12 | 고에키 자이단 호징 센탄 이료 신코 자이단 | 경도 인지 장해의 예방 및/또는 치료제 |
| WO2015100255A2 (en) * | 2013-12-23 | 2015-07-02 | Holaday John W | Disposable container for air hydration |
| WO2017199755A1 (ja) * | 2016-05-19 | 2017-11-23 | 国立研究開発法人国立循環器病研究センター | 認知症の予防及び／又は治療のための薬剤 |
| MX385719B (es) | 2017-05-24 | 2025-03-18 | H Lundbeck As | Combinacion de un antagonista del receptor 5-ht6 y un inhibidor de acetilcolinesterasa para su uso en el tratamiento de la enfermedad de alzheimer en una subpoblacion de pacientes portadores de alelos apoe4 |
| CN107602523B (zh) * | 2017-09-11 | 2020-08-18 | 安徽中医药大学 | 京尼平类似物、制备方法及其应用 |
| PL237739B1 (pl) | 2018-06-06 | 2021-05-17 | Univ Gdanski | Genisteina do zastosowania do leczenia choroby Alzheimera |
| NL2024431B1 (en) | 2019-12-11 | 2021-09-07 | Sulfateq Bv | Compounds for treatment of alzheimer’s disease |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5535019A (en) | 1978-09-01 | 1980-03-11 | Otsuka Pharmaceut Co Ltd | Carbostyryl derivative |
| JPS5649378A (en) | 1979-08-25 | 1981-05-02 | Otsuka Pharmaceut Co Ltd | Tetrazolylalkoxycarbostyril derivative |
| FI95572C (fi) | 1987-06-22 | 1996-02-26 | Eisai Co Ltd | Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi |
| JP2574099B2 (ja) | 1992-05-21 | 1997-01-22 | 大塚製薬株式会社 | アレルギー疾患治療剤 |
| JPH10175864A (ja) | 1996-12-16 | 1998-06-30 | Otsuka Pharmaceut Co Ltd | 慢性閉塞性肺疾患治療剤 |
| US6019735A (en) * | 1997-08-28 | 2000-02-01 | Visco Technologies, Inc. | Viscosity measuring apparatus and method of use |
| US6322524B1 (en) * | 1997-08-28 | 2001-11-27 | Visco Technologies, Inc. | Dual riser/single capillary viscometer |
| US6322525B1 (en) * | 1997-08-28 | 2001-11-27 | Visco Technologies, Inc. | Method of analyzing data from a circulating blood viscometer for determining absolute and effective blood viscosity |
| US6428488B1 (en) * | 1997-08-28 | 2002-08-06 | Kenneth Kensey | Dual riser/dual capillary viscometer for newtonian and non-newtonian fluids |
| EP1047674B1 (en) * | 1998-01-16 | 2005-03-30 | Eisai Co., Ltd. | Process for production of donepezil derivatives |
| US6187790B1 (en) * | 1999-03-04 | 2001-02-13 | Neal R. Cutler | Use of cilostazol for treatment of sexual dysfunction |
| US6267985B1 (en) * | 1999-06-30 | 2001-07-31 | Lipocine Inc. | Clear oil-containing pharmaceutical compositions |
| US6294192B1 (en) * | 1999-02-26 | 2001-09-25 | Lipocine, Inc. | Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents |
| US6484565B2 (en) * | 1999-11-12 | 2002-11-26 | Drexel University | Single riser/single capillary viscometer using mass detection or column height detection |
| US6458804B1 (en) * | 2001-01-26 | 2002-10-01 | R.T. Alamo Venturesi, Llc | Methods for the treatment of central nervous system disorders in certain patient groups |
| TW200301135A (en) * | 2001-12-27 | 2003-07-01 | Otsuka Maryland Res Inst Inc | Pharmaceutical compositions comprising a multifunctional phosphodiesterase inhibitor and an adenosine uptake inhibitor |
| IL150509A (en) * | 2002-07-01 | 2007-07-04 | Joseph Kaspi | Pharmaceutical preparations containing donafazil hydrochloride |
| US6743806B2 (en) * | 2002-10-23 | 2004-06-01 | Otsuka Pharmaceutical Company, Limited | Active oxygen scavenger |
| FR2848452B1 (fr) * | 2002-12-12 | 2007-04-06 | Aventis Pharma Sa | Application des inhibiteurs de recapture intestinale des acides biliaires pour la prevention et le traitement de la maladie d'alzheimer |
| JP2004189706A (ja) * | 2002-12-13 | 2004-07-08 | Eisai Co Ltd | 高度アルツハイマー型痴呆治療剤 |
| TWI323660B (en) * | 2003-02-25 | 2010-04-21 | Otsuka Pharma Co Ltd | Pten inhibitor or maxi-k channels opener |
-
2008
- 2008-05-21 RU RU2009147456/15A patent/RU2469723C2/ru not_active IP Right Cessation
- 2008-05-21 JP JP2010509026A patent/JP5153870B2/ja not_active Expired - Fee Related
- 2008-05-21 TW TW102147146A patent/TWI489983B/zh not_active IP Right Cessation
- 2008-05-21 MY MYPI20094815A patent/MY146407A/en unknown
- 2008-05-21 TW TW097118634A patent/TWI423802B/zh not_active IP Right Cessation
- 2008-05-21 PL PL08764779T patent/PL2157973T3/pl unknown
- 2008-05-21 BR BRPI0811919-8A2A patent/BRPI0811919A2/pt not_active IP Right Cessation
- 2008-05-21 NZ NZ581099A patent/NZ581099A/en not_active IP Right Cessation
- 2008-05-21 KR KR1020097026651A patent/KR101441725B1/ko not_active Expired - Fee Related
- 2008-05-21 MX MX2009012583A patent/MX2009012583A/es active IP Right Grant
- 2008-05-21 AU AU2008253977A patent/AU2008253977B2/en not_active Ceased
- 2008-05-21 WO PCT/JP2008/059763 patent/WO2008143361A1/en not_active Ceased
- 2008-05-21 HR HRP20150843TT patent/HRP20150843T1/hr unknown
- 2008-05-21 EP EP15164200.6A patent/EP2937085B1/en active Active
- 2008-05-21 DK DK08764779.8T patent/DK2157973T3/en active
- 2008-05-21 UA UAA200913247A patent/UA96633C2/uk unknown
- 2008-05-21 CN CN2008800167568A patent/CN101754758B/zh not_active Expired - Fee Related
- 2008-05-21 HU HUE08764779A patent/HUE025902T2/en unknown
- 2008-05-21 SI SI200831493T patent/SI2157973T1/sl unknown
- 2008-05-21 US US12/599,962 patent/US20100298375A1/en not_active Abandoned
- 2008-05-21 PT PT87647798T patent/PT2157973E/pt unknown
- 2008-05-21 EP EP08764779.8A patent/EP2157973B1/en not_active Not-in-force
- 2008-05-21 CA CA2687289A patent/CA2687289C/en not_active Expired - Fee Related
- 2008-05-21 AR ARP080102154A patent/AR066664A1/es unknown
- 2008-05-21 ES ES08764779.8T patent/ES2545959T3/es active Active
-
2009
- 2009-11-11 IL IL202053A patent/IL202053A/en not_active IP Right Cessation
- 2009-11-20 ZA ZA200908202A patent/ZA200908202B/xx unknown
- 2009-12-21 CO CO09145995A patent/CO6251249A2/es active IP Right Grant
-
2015
- 2015-09-14 CY CY20151100797T patent/CY1116683T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200908202B (en) | A medicament comprising a carbostyril derivates and donepezil for treating alzheimer's disease | |
| EP2091566A4 (en) | COMBINATION THERAPIES AGAINST ALZHEIMER DISEASE AND SIMILAR ILLNESSES | |
| IL195668A0 (en) | Amino-imidazolones and their use as a medicament for treating cognitive impairment, alzheimer disease, neurodegeneration and dementia | |
| IL195574A0 (en) | Amino-imidazolones and their use as a medicament for treating cognitive impairment, alzheimer disease, neurodegeneration and dementia | |
| PL1993365T3 (pl) | Preparaty z biodostępnych kurkuminoidów do leczenia choroby alzheimera oraz innych zaburzeń powiązanych z wiekiem | |
| IL219412A (en) | Preparations containing Busimanden for use in the treatment of Alzheimer's or Alzheimer's disease | |
| EP2151435A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALZHEIMER'S DISEASE | |
| ZA201007460B (en) | Use of epothelone in treating tau-associated disease including alzheimer's disease | |
| PL1965816T3 (pl) | Kompozycje farmaceutyczne i sposoby leczenia lub zapobiegania chorobom związanym ze szczawianami | |
| IL209894A (en) | Compounds for the prevention and / or treatment of β-amyloidosis including Alzheimer's disease | |
| EP2485733A4 (en) | METHODS FOR THE TREATMENT OF ALZHEIMER'S DISEASE | |
| EP2306824A4 (en) | IONTOPHORETIC DELIVERY OF CURCUMINE AND CURCUMINANALOGUE FOR THE TREATMENT OF MORBUS ALZHEIMER | |
| ZA200810528B (en) | Procedure and methods for detecting Alzheimer's disease | |
| TWI369210B (en) | Use of lgg in the manufacture of a medicament for the prevention or treatment of respiratory allergies | |
| IL185444A0 (en) | Novel drugs for treating respiratory diseases | |
| ZA201101752B (en) | A medicinal product and treatment | |
| PL2182966T3 (pl) | Zastosowanie ekstraktów lub substancji ekstrahowanych z Piper cubeba L. jako składników czynnych leku do leczenia chorób nowotworowych | |
| EP2565184B8 (en) | Therapeutic agent and preventative agent for alzheimer's disease | |
| IL177609A (en) | Use of gobacoline or its analogue to produce a drug to treat liver carcinoma | |
| EP2099476A4 (en) | METHODS OF TREATING ALZHEIMER'S DISEASE | |
| HUP0600409A3 (en) | Izatin and it's derivatives for use as a medicine | |
| TWI341204B (en) | Composition and method for prevention and treatment of alzheimer's disease | |
| GB0811555D0 (en) | Treatment of Alzheimer's disease | |
| ZA200810175B (en) | Amino-imidazolones and their use as a medicament for treating cognitive impairment. Alzheimer disease, neurode-generation and dementia | |
| GB0505237D0 (en) | Pharmacological drug therapy for alzheimer's disease |